| Pharmaceutical Information |
| Drug Name |
Metaxalone |
| Drug ID |
BADD_D01400 |
| Description |
Metaxalone is a moderate to strong muscle relaxant used in the symptomatic treatment of musculoskeletal pain caused by strains, sprains, and other musculoskeletal conditions. It is marketed by King Pharmaceuticals under the brand name Skelaxin®. Its main mechanism of action is thought to involve general central nervous system depression. Metaxalone is associated with few side effects and is available as a 800 mg scored tablet. |
| Indications and Usage |
For the treatment of painful peripheral musculoskeletal conditions and spasticity from upper motor neuron syndromes. |
| Marketing Status |
approved |
| ATC Code |
Not Available |
| DrugBank ID |
DB00660
|
| KEGG ID |
D00773
|
| MeSH ID |
C011301
|
| PubChem ID |
15459
|
| TTD Drug ID |
D0S5CH
|
| NDC Product Code |
50228-323; 50228-474; 55700-911; 61919-832; 64980-472; 67296-1577; 68001-004; 68001-485; 68084-135; 69097-998; 0527-1435; 80425-0131; 12666-0012; 42494-449; 50268-530; 50436-0449; 53746-553; 67296-0993; 70518-0818; 75945-070; 0115-1745; 60687-663; 68040-712; 71205-961; 71335-0958; 63187-490; 63629-2398; 71205-326; 80425-0084; 65977-0089; 42291-587; 51655-602; 67296-1275; 70518-0771; 70934-429; 71205-016; 71335-1320; 17511-104; 50056-1999; 45865-985; 55700-494; 60760-289; 61919-091; 68788-7675; 69306-100; 45865-942; 51655-792; 0276-0508; 67296-1778; 68071-2849; 0904-6831; 60760-093; 63629-8014; 68788-7018; 69306-311; 0591-2341; 71335-2066; 0185-0448; 51655-171; 71205-426; 71205-470; 72789-028; 72789-122; 76420-232; 10920-581; 63629-2097; 65162-553; 68788-7499; 70518-2275; 70934-286; 80425-0122; 47621-020; 52076-6231; 73680-0011; 50090-3650; 55111-650 |
| UNII |
1NMA9J598Y
|
| Synonyms |
metaxalone | Skelaxin | AHR 438 |
|
| Chemical Information |
| Molecular Formula |
C12H15NO3 |
| CAS Registry Number |
1665-48-1 |
| SMILES |
CC1=CC(=CC(=C1)OCC2CNC(=O)O2)C |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
